Comments invited on draft revised guideline on medicines for the treatment of hypertension
NewsHumanRegulatory and procedural guidance
Czech is available via eTranslation, the European Commission's machine translation service.
Translate to Czech | Important information about machine translation
The European Medicines Agency has released a draft revision of its Draft guideline on clinical investigation of medicinal products in the treatment of hypertension - Revision 4 for a six-month public consultation.
Comments should be made using the submission form and sent no later than 31 January 2014 to cvswpsecretariat@ema.europa.eu.
This is the fourth revision of this guideline. Its main purpose is to include more comprehensive guidance on the collection of long-term safety data and to clarify the situations in which outcome studies might be required in order to detect potential long-term effects on mortality and morbidity.